Literature DB >> 30663590

The costs of drug prescriptions for diabetes in the NHS.

Mike Stedman1, Mark Lunt2, Mark Livingston3, Anthony A Fryer4, Gabriela Moreno5, Susan Bailey6, Roger Gadsby7, Adrian Heald8.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30663590     DOI： 10.1016/S0140-6736(18)33190-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Changes in glycaemic control of oral anti-diabetic medications assessed by continuous glucose monitors among patients with type 2 diabetes: a protocol of network meta-analysis.

Authors:  Mingyue Zheng; Adeel Khoja; Anamica Patel; Yunting Luo; Qian He; Xuan Zhao; Shenqiao Yang; Peng Hu; Wei Lin
Journal:  Syst Rev       Date:  2022-06-02

2.  Prescribing costs of hypoglycaemic agents and associations with metabolic control in Wales; a national analysis of primary care data.

Authors:  Peter N Taylor; Qi Zhuang Siah; Omar Marei; Mia McDade-Kumar; Nasser Rachedi; Robert Bracchi; Richard Boldero; Kath Haines; Mohammed Alhadj Ali; Robert French; Colin M Dayan
Journal:  Diabet Med       Date:  2022-07-19       Impact factor: 4.213
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.